Close

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more

26 Feb 2010
FDA Press Release - FDA Approves Therapy to Treat Gaucher Disease

New drug will offer a treatment alternative for patients with rare genetic disorder

SILVER SPRING, Md., Feb. 26 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease.

See the FDA's full press release here.

SOURCE U.S. Food and Drug Administration

« Back to Shire news

Did you know...

You can sign up to receive email and SMS alerts so that you can keep up to speed with our latest news.

Email and SMS alerts

Did you know...

We donated over $35,000 in
outdated laboratory
equipment
to local
schools?